Emrosi Versus Doxycycline for Rosacea

Emrosi is a particular minocycline formulation: each 40 mg capsule contains 10 mg released immediately and 30 mg released over time. Its US indication covers rosacea’s inflammatory bumps and pustules in adults. It has not been evaluated for treating or preventing infections. Other minocycline products are not equivalent in drug exposure, according to its label.¹

What was compared?

Two 16-week trials randomized 653 adults with moderate to severe rosacea; about three-quarters were women. Mean ages were 47 and 52. Participants took Emrosi 40 mg, modified-release doxycycline 40 mg, or placebo daily.²

How much did it help?

Success meant clear or almost-clear skin plus a two-grade improvement. Success rates were 65.0% versus 46.1% in MVOR-1 and 60.1% versus 31.4% in MVOR-2, comparing Emrosi with doxycycline. This assessment scored inflammatory lesions, excluding redness.²

Adverse-event rates for Emrosi versus doxycycline were 26.4% versus 21.6% in MVOR-1, and 41.8% versus 33.1% in MVOR-2. These trials cannot settle rare harms or long-term safety.²

Does that settle the treatment choice?

Ask which feature needs treatment. The American Academy of Dermatology³ describes separate options for persistent facial color, visible blood vessels, acne-like bumps and eye symptoms. A bump score cannot answer all those questions. Our rosacea overview can help describe the features you want assessed.³

Emrosi’s label warns about serious allergic reactions, liver injury, dizziness, pigmentation changes and raised pressure around the brain. Tell the prescriber about pregnancy plans, breastfeeding and tetracycline allergies. The label advises against taking it with isotretinoin; antacids containing calcium, magnesium or aluminum and iron preparations can impair absorption. Stop Emrosi and contact the prescriber promptly for unusual headaches or blurred or double vision.¹

What belongs in the follow-up plan?

Arrange a review date and ask how bumps, lasting color and tolerability will be recorded separately. Gentle cleansing, moisturizer, sun protection and trigger management remain part of rosacea care. Once symptoms are controlled, the dermatologist may switch to a maintenance plan.³

Skin, Head to Toe describes a Skin Log with photographs in consistent light and notes on warmth, stinging and bump counts. Bring those observations and your treatment start date to the review. See the book.